Abstract
The pharmacokinetics of abamectin (ABM) following a single subcutaneous administration of 200 μg/kg was evaluated in adult fallow deer by following ABM concentration in blood plasma. A nonlinear mixed effects modelling procedure was used for pharmacokinetic analysis. The time course of ABM concentration was described by a two-compartment model with first-order absorption. Abamectin absorption in fallow deer was rapid with a peak plasma concentration of 120.7 ± 33.2 ng/mL observed at 19.1 ± 7.7 h (mean ± SD). Half-lives of the distribution and terminal phase were 17.2 and 119.3 h, respectively. Typical apparent clearance of the bioavailable fraction (CL/F) was 0.795 L/h and was independent of animal weight. Considering the obtained pharmacokinetic parameters in our study, we may assume that effective parasite control in fallow deer is obtained using the usual recommended dose of 200 μg/kg.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Journal of Veterinary Pharmacology and Therapeutics
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
